I G Petrochemicals Limited (IGPL.NS)
Mumbai, IN
Based in Mumbai, India, and founded in 1988, I G Petrochemicals Limited operates as a producer and global distributor of organic chemicals. Its product lineup features phthalic anhydride, an essential component for plasticizers, alkyd resins, paints, unsaturated polyester resins, and CPC pigments. Another significant offering is maleic anhydride, an organic compound crucial for the creation of spandex, unsaturated polyester resins, lubricating oil additives, personal care items, water treatment detergents, insecticides, and fungicides. The company also provides benzoic acid, an organic substance widely utilized in perfumes, dyes, topical medications, insect repellents, and food preservatives. Completing its range are advanced plasticizers, employed in the production of incense sticks, fragrances, and plastic packaging films.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.19% | -6.11% | +1.66% | +16.04% | +14.23% | +7.93% | -9.23% | -9.71% | -22.02% | +202.40% | +484.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-12.8% Q1'26: +9.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-98.0% Q1'26: +47.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-2.8% Q1'26: -22.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+1.3% Q1'26: +8.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.1% Q1'26: +9.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.82× Q1'26: 1.36× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.37B
est: 10.37B (+0.0%)
|
11.44B
est: 11.66B (-1.8%)
|
13.04B
est: 12.53B (+4.1%)
|
10.59B
est: 12.42B (-14.8%)
|
11.24B
est: 10.68B (+5.2%)
|
18.83B
est: 18.83B (0.0%)
|
23.52B
est: 22.68B (+3.7%)
|
20.94B
est: 20.67B (+1.3%)
|
22.06B
est: 23.06B (-4.3%)
|
18.87B
18.87B – 18.87B
-18.2% YoY
|
25.41B
25.41B – 25.41B
+34.7% YoY
|
29.77B
29.77B – 29.77B
+17.1% YoY
|
| EBITDA |
1.63B
est: 1.64B (-0.8%)
|
2.67B
est: 1.70B (+57.3%)
|
2.21B
est: 2.72B (-18.9%)
|
726.89M
est: 2.10B (-65.4%)
|
2.97B
est: 613.01M (+383.8%)
|
4.14B
est: 777.92M (+431.6%)
|
3.40B
est: 880.02M (+285.9%)
|
1.36B
est: 3.27B (-58.5%)
|
2.19B
est: 2.66B (-17.8%)
|
2.18B
2.18B – 2.18B
-18.2% YoY
|
2.93B
2.93B – 2.93B
+34.7% YoY
|
3.44B
3.44B – 3.44B
+17.1% YoY
|
| EBIT |
1.42B
est: 1.38B (+3.5%)
|
2.42B
est: 1.71B (+41.6%)
|
1.94B
est: 2.58B (-24.8%)
|
427.89M
est: 1.77B (-75.9%)
|
2.63B
est: 452.04M (+482.5%)
|
3.69B
est: 573.65M (+543.6%)
|
2.92B
est: 648.94M (+350.3%)
|
838.17M
est: 2.74B (-69.4%)
|
1.54B
est: 2.04B (-24.8%)
|
1.67B
1.67B – 1.67B
-18.2% YoY
|
2.25B
2.25B – 2.25B
+34.7% YoY
|
2.64B
2.64B – 2.64B
+17.1% YoY
|
| Net Income |
1.02B
est: 1.02B (0.0%)
|
1.46B
est: 1.18B (+24.0%)
|
1.17B
est: 1.56B (-25.1%)
|
208.78M
est: 1.10B (-81.1%)
|
1.88B
est: 208.11M (+803.9%)
|
2.65B
est: 264.09M (+901.6%)
|
2.00B
est: 298.76M (+569.5%)
|
395.13M
est: 314.17M (+25.8%)
|
1.09B
est: 1.19B (-8.4%)
|
-228.10M
-228.10M – -228.10M
-119.2% YoY
|
172.61M
172.61M – 172.61M
+175.7% YoY
|
1.29B
1.29B – 1.29B
+648.2% YoY
|
| SGA |
283.78M
est: 289.43M (-2.0%)
|
300.66M
est: 971.69M (-69.1%)
|
356.01M
est: 1.23B (-71.0%)
|
355.06M
est: 1.25B (-71.5%)
|
390.89M
est: 1.28B (-69.5%)
|
521.58M
est: 1.62B (-67.9%)
|
533.79M
est: 1.84B (-70.9%)
|
595.27M
est: 576.67M (+3.2%)
|
571.00M
est: 1.04B (-45.0%)
|
848.61M
848.61M – 848.61M
-18.2% YoY
|
1.14B
1.14B – 1.14B
+34.7% YoY
|
1.34B
1.34B – 1.34B
+17.1% YoY
|
| EPS |
32.98
est: 32.98 (+0.0%)
|
47.42
est: 49.47 (-4.1%)
|
37.94
est: 41.95 (-9.6%)
|
6.78
est: 12.00 (-43.5%)
|
61.08
est: 47.55 (+28.5%)
|
85.89
est: 85.90 (0.0%)
|
64.95
est: 64.40 (+0.9%)
|
12.83
est: 10.20 (+25.8%)
|
35.29
est: 38.50 (-8.3%)
|
-7.40
-7.40 – -7.40
-119.2% YoY
|
5.60
5.60 – 5.60
+175.7% YoY
|
41.90
41.90 – 41.90
+648.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nikunj Dhanuka | Chairman & MD | 39M | male |
| Sagar Jadhav | Executive Director | 13M | male |
| Mayank Dhanuka | President, Executive Director & Chief Executive Officer | 4M | male |
| Sudhir R. Singh | Compliance Officer & Company Secretary | 3M | male |
| V. Rajkumar | Chief Human Resources Officer | — | — |
| Pramod Bhandari | Chief Financial Officer | — | male |
| Sanjay Gupta | President of New Business Initiatives | — | male |
| Umang Dhanuka | Chief Marketing Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IGPL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
